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Abstract
Background: Crohn's disease (CD) is clinically expressed as a chronic affection of the gastrointestinal tract currently 
known to have a multifactorial etiology involving a complex pathophysiological host response modulated by genetic 
susceptibilities, demographic determinants and environmental factors. With more than 20 cases per 100,000 person-
years, the province of Quebec, Canada is among regions of the world with highest reported occurrence of CD in 
relation to other places where comparable estimates are available. This ecological study was designed to provide a 
medium-scale spatial exploration of CD incidence after accounting for the influence of known population and regional 
determinants. Health records of consulting patients in southern Quebec were compiled from 1995 to 2000 and used to 
estimate age and sex standardized rates per health area (n = 156). Various statistical models taking into account the 
regional effect of Jewish ethnicity, aboriginal ancestry, material deprivation, prescription for oral contraceptives, 
reportable enteric infection incidence, smoking as well as latitude and longitude locations were fitted.
Results: The final regression model presented a coefficient of determination of 22.8% and there was evidence of an 
eastern trend in the residual incidence (p = 0.018). Overall, the smoothed residual incidence presented a 
heterogeneous spatial pattern with evidence of patches (multiple health areas) of high, low and contrasting values. 
Health areas with most extreme incidence residuals where also distributed over the whole province including one area 
in the metropolitan area of Montreal and others in surrounding areas.
Conclusions: These findings suggest that known populational and regional factors derived through census 
information only explain a limited fraction of the geographical variation of CD incidence and lead to speculate that the 
effects of these factors may be incompletely captured (imperfect construction of proxy variables) or that other 
important factors remain unmeasured. In this view, markers of genetic profiles of homogeneous sub-populations, and 
other factors linked to agroenvironmental microbial exposure should be further investigated. Once accounting for 
known factors, it would also be worth comparing adjacent geographical areas demonstrating abrupt changes in 
residual incidence rates to further explore effect linked to regional factors from those resulting from various reporting 
systems.
Background
Ulcerative colitis and Crohn's disease (CD) are the two
major types of inflammatory bowel diseases (IBD). CD
affects the gastrointestinal tract, from the mouth to the
anus and is known to have a multifactorial etiology
involving genetic predispositions, demographic determi-
nants and environmental factors [1]. The increasing fre-
quency of IBD has been put in parallel with the
development and modernization of the society, but they
can also be linked with changes in individuals and life
habits [2]. With an estimated 13.4 new cases/105 persons,
Canada has one of the highest rates of Crohn's disease
recorded in the world and its epidemiology shows a geo-
graphical variation of the incidence distribution [3]. Spa-
tially heterogeneous distributions of the disease have
been observed in distinct parts of the world [4,5] and var-
ious regional-level risk factors relating to population
characteristics and possible environmental exposures
have been proposed in explaining the spatial variation in
the occurrence of CD [6-10]. A recent study aiming at
describing the occurrence and key regional factors linked
to the condition in the province of Quebec, Canada,
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showed that some regional factors, namely the enteric
disease incidence, the proportion of people of Jewish eth-
nicity and the proportion of immigrant people were sig-
nificant predictors of incidence of CD in this population
[11].
Given the current state of knowledge on CD spatial epi-
demiology, we hypothesized that known regional factors
only account for a small fraction of the total geographical
variation of CD incidence and that a spatial investigation
of residual variation could further revealed geographical
patterns that might contribute to our knowledge of the
role of environmental or population factors linked to this
condition. This analysis is therefore aimed to explicitly
describe medium-scale spatial distribution of CD resid-
ual incidence adjusted for a set of known regional predic-
tors in the province of Quebec, Canada.
Methods
Study setting
This ecological study was designed as a spatial explora-
tion in follow-up to an epidemiological investigation by
Lowe et al. [11] presenting the association of regional-
level factors with CD in the province of Quebec. The geo-
graphical unit of interest was defined based on the small-
est health division in this province and are referred herein
as "health area" (N = 166, according to the 2006 boundar-
ies). Patient records in the provincial databases specifi-
cally include the designation of these health areas. To
further increase the specificity of the results, and in con-
sideration of sparse population density and relatively
large territories, the ten most northern health areas
(north of 50 degree of latitude approximately) of the
province (regrouping 0.62% of the total provincial popu-
lation) were excluded from the analysis. The selection of
the geographical unit and area of interest were designed
in consideration of the stability of the epidemiological
measures (standardized incidence rates), the potential for
geographical misclassification errors of records, the
desire to minimize possible ecological biases and the
structure of the spatial connectivity required for the anal-
ysis given the geography of the province under study. The
population of interest consisted of an average of 7.2 mil-
lion people (1996 census).
Data
CD is not a reportable disease in the province of Quebec,
Canada. Therefore, cases of CD consisted of residents of
Quebec that were entered in the computerized adminis-
trative health databases of this province ("Régie de
l'Assurance Maladie du Québec", RAMQ and MED-
Echo). These databases were developed in the context of
the universal insurance program and for recording hospi-
tal discharge information. The database on medical ser-
vice claims includes more than 99% of the population
[12]. In order to be reimbursed by the program, physi-
cians submit to the RAMQ a claim for each medical visit,
recording the data and location of the medical service as
well as the procedure code for the service provided and
the ICD-9 code for the diagnosis. Because of its popula-
tion-based coverage and routine audits, information from
these databases is deemed valid and consistent [13,14].
Health records for the period extending from January 1st,
1993 to December 31st, 2002 were examined and those
between 1995 and 2000 were considered for defining
incident cases. Details relating to the case definition and
validation have been previously described by Bernstein et
al. [3] and Lowe et al. [11]. Cumulative rates (incidence)
were calculated using the mid-year 1996 Quebec popula-
tion for each health area and age-sex direct internal stan-
dardization was performed using the overall provincial
age-sex distribution.
Statistical analyses
The statistical modeling strategy aimed primarily at
describing the spatial distribution of residual incidence
accounting for known population and demographic risk
factors. As such, we were not seeking to study other fac-
tors than those presented by Lowe et al. (2009) [11].
These were: proportions of the population reporting to
be immigrants, of Jewish ethnicity and of aboriginal
ancestry, as well as measures of material deprivation,
number of prescription for oral contraceptives, report-
able enteric infection incidence and smoking. These
"population-driven" variables were offered and selected in
a stepwise approach leading to a reduced model. To test
the residual effect of urban/rural location and if geo-
graphical trend was left in the reduced model, the latitude
and longitude of the ecoumen of the health areas and a
variable describing the level of urbanicity of health areas
were also tested for significance. Various model struc-
tures, namely Poisson, negative-binomial, spatially
explicit (spatial error and spatial lag) and linear multivari-
able models were developed and assessed as for their fit,
and interpretation. A multivariate linear model was kept
as the main model in consideration of a lack of spatial
error or spatial lag effects, and to retain an easily inter-
pretable outcome variable. The outcome variable was
designated as the area level cumulative incidence directly
standardized for age and sex (DSR). Significance of pre-
dictors was derived using a robust variance estimation
(Huber and White) accounting for possible cluster effect
(broader regional health districts, n = 12). Residual stan-
dardized incidence rates were smoothed using the empir-
ical Bayes method to further address the stability of the
rate estimates given heterogeneous population sizes.
Moran's I statistics was computed for residual incidence
rates. Local Indicators of Spatial Autocorrelation (LISA)
were also calculated to study possible local clustering pat-Michel et al. International Journal of Health Geographics 2010, 9:22
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tern. In this analysis, the LISA were represented by local
Moran's I values. Health areas with significant LISA were
classified as "High-High", "Low-Low", "High-Low" or
"Low-High" according to the location of their respective
standardized value within the four quadrants of an uni-
variate Moran scatter plot [15]. An inverse distance spa-
tial connectivity matrix based on the centroid of the
population ecoumen was used for the spatially explicit
regression models and for the LISA. The statistical mod-
eling was performed using the software STATA (Stata/SE
8.2, 2005). Empirical Bayes Smoothing (EBS) and LISA
statistics were calculated using the software GeoDA
(GeoDa, 0.9.5-i5, 2004).
Mapping
In map representations, classification of the outcomes of
interest (EBS-CD incidence, and EBS-CD incidence
residuals) was done using a bi-directional standard devia-
tion method using five classes where the "average" class
included values within 0.5 standard deviation of the
mean, the "low" and "high" classes included values
between 0.5 and 1.0 standard deviation from the mean
and the "very high" and "very low" classes included values
1.0 standard deviation from the mean. Classification and
map representation were done using the software ArcGIS
9.3 (ESRI, 2008).
Results
CD incidence
From January 1st, 1995 to December 31st, 2000, a total of
10,033 CD cases were recorded over the 156 health areas
of southern Quebec, which correspond to a yearly mean
crude rate of 23.2 per 105 person-year. For the 156 health
areas under study, the age-sex standardized cumulative
incidence was estimated at 13.9 cases per 104 persons
(95% CI: 13.3 - 14.5). There were 70 (44.9%) health areas
that were classified as having an average incidence.
Multivariable regression model
Estimated parameters of the main multivariable linear
regression model are presented in Table 1. The depen-
dant variable was CD standardized cumulative incidence.
In this main model, the proportion of immigrant people
and proportion of population of aboriginal ancestry in
the Quebec population both had a statistically significant
negative effect (protective effect) on the dependant vari-
able, whereas the variable describing the proportion of
population of Jewish ethnicity had a significant positive
association with CD standardized cumulative incidence.
A non-significant negative association was found
between the dependant variable and the variable describ-
ing an increasing level of material deprivation (MAT) and
a non-significant positive association was found with
reportable enteric infections incidence (ENT). Both the
MAT and ENT were forced into the model which pre-
sented a coefficient of determination of 22.8%. When lati-
tude and longitude variables corresponding to the
geographical centroid of the population ecoumen of the
health areas were added to the main model, a statistically
positive association (P = 0.018) was found for the longi-
tude (eastern trend). A variable describing the urban or
rural aspect of the health region was also offered to the
main model but was non-significant (P = 0.64).
Distribution of EBS standardized incidence and residual 
incidence rates
The spatial distribution of the EBS CD standardized
cumulative incidence in southern Quebec followed an
overall heterogeneous pattern. Some regions included
health areas with very high rates, other regions showed
homogeneous patches of health areas with low and very
low rates and several locations showed a combination of
high and low incidence, the highest incidence areas being
adjacent to lower incidence areas (Figure 1). After
accounting for the effect of selected factors in the main
model (Table 1), the spatial distribution of regional EBS
cumulative incidence residuals was also heterogeneous,
presenting a similar but more contrasted pattern when
compared to the distribution of the incidence rates. In
Figure 2, positive values reflect a larger observed inci-
dence than the one predicted by the model (under-esti-
mation by the model) and negative values reflect a
smaller observed incidence than the one predicted by the
model (over-estimation by the model). Patches of health
areas with lower values such as regions identified as A
and E, higher values (i.e. regions B and F) and with dis-
cordant values (i.e. regions D and C) were spread over the
province with no specific geographical pattern. For the
Island of Montreal (Figure 2, inset), the areas correspond-
ing to the greater downtown sectors had, for the most
part, large or very large negative residuals and the rest of
the island presented overall large positive residuals. For
Quebec city (not shown), the second largest metropolitan
area after Montreal in this province, the upper town area
(including the business downtown and tourist center)
presented large negative residuals and the lower town
area, the sub-urban northern and southern areas of the
city showed large and very large positive residuals.
Spatial autocorrelation
There was evidence of statistically significant (P < 0.05)
local pockets of spatial autocorrelation (local area of clus-
tering), both for positive values and negative values for
the residual incidence of CD in southern Quebec (Figure
3). A total of 11 areas had significant LISA for positive
residuals (high/high). Among these, we noted that six of
them were in the greater Montreal area. A total of nine
areas had significant LISA for negative residuals (low/Michel et al. International Journal of Health Geographics 2010, 9:22
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low) with four of these clustering in a large area north of
Montreal (Figure 3 - inset) and the others in various loca-
tions. There were also 14 areas with significant LISA val-
ues and describing discordance between areas with
positive and negative values (high/low or low/high). The
overall spatial distribution of these local indices led to no
evidence of global spatial autocorrelation (Moran's I = -
0.000263, P = 0.30).
Most extreme values
A total of nine health areas in Quebec were described as
"areas with largest residuals" after accounting for the
expected effect of the known regional risk factors (Figure
4). Of these, five had large positive EBS residual values
and four had large negative EBS residuals values. Both
positive and negative largest residual values areas were
located in various location of the study area.
Discussion
Although Crohn's Disease (CD) has been recognized as
an important health condition in various developed
countries for many years, the understanding of its epide-
miology is still incomplete [1]. One of the important goals
in studying the geographical distribution of complex
health conditions such as CD lies on the desire to identify
consistent, specific and influential exposures as well as
determinants on which medical and public health actions
could be targeted. This retrospective investigation of
Quebec CD data allowed us to emphasize an apparent
spatial heterogeneity observed in the distribution of the
CD incidence residuals once controlling for effects from
various known factors. Local aggregations (clustering) of
areas with high, low or mixed (high/low) residual inci-
dence rates were noted in various locations of the prov-
ince with no clear pattern.
As discussed by Elliot et al., the observation of an
apparent spatially heterogeneous distribution of a health
condition may reflect the overall variations of multiple
interconnected factors that might play a role of variable
importance in the etiology of that condition [16]. Factors
such as smoking habits, socio-economical status, urban
setting, immigration and specific ethnic profiles such as
Ashkenazi Jewish and Aboriginal origins are among
recently reported factors that have been highlighted as
modulating the regional occurrence of the condition. The
possible contribution of these broad factors have led to
various theories and speculations implicating the possible
effect of diet [17-20], occupation [21-23], allergens
[24,25], sunlight [26,27] and microbial exposure in the
risk of developing CD [28,29]. In the context of a multi-
factorial disease such as CD, the heterogeneous spatial
distribution might reflect therefore the complex interac-
tion of many factors, each of them with a specific local
relationship with population and environmental charac-
teristics. Further characterization of these influences in
term of their small and medium scale geographical pat-
tern, and their assessment as to improving geographical
models for CD incidence could be of great value in the
effort of decomposing the apparent complex geographi-
cal variation of this condition.
In this study, an attempt was made to remove effects
from a few known regional factors and the analysis of
residual values of CD incidence revealed a distribution
somehow similar to, but more contrasted than the one
describing the non-adjusted CD incidence. This result
suggests that important variables might be missing or
Table 1: Regression Model of Directly Standardized Incidence of CD
95% Confidence Interval
Variables Coefficients Robust SE T-values P-values Lower Upper
Immigration -0.14 0.01 -12.19 <0.01 -0.16 -0.11
Jewish 
ethnicity
0.23 0.02 11.98 <0.01 0.19 0.27
Aboriginal 
ancestry
-0.22 0.05 -4.14 <0.01 -0.34 -0.11
Material 
deprivation
-0.96 0.49 -1.96 0.07 -2.00 0.09
Reported 
Enteric 
infection
0.06 0.05 1.09 0.29 -0.05 0.17
Constant 15.87 1.03 15.38 <0.01 13.66 18.08
Regression model coefficients were estimated using robust standard error procedure. Model includes the regional effect of immigration, 
population of Jewish ethnicity, population of aboriginal ancestry, material deprivation and incidence of enteric diseases (n = 156), R2 = 
0.2284.Michel et al. International Journal of Health Geographics 2010, 9:22
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that the construction of those selected may be imperfect.
Using various modeling strategies, our data consistently
suggested that approximately 20% of the overall regional
variation in CD incidence in the province was explained
by the combined effect of immigration, Jewish origin,
Aboriginal origin, the level of enteric infection and a
measure of socio-economic status. These observations
are consistent with what has been previously shown in
another Canadian province [30]. However, the construc-
tion of variables such as "proportion of immigrant" and
"proportion of population from a Jewish ethnicity" from
census information are likely to represent incomplete
proxy measures for capturing the potential effect of sub-
population genetic profiles that could be linked to CD. At
a smaller scale, the contrasted pattern seen both in Mon-
treal and Quebec cities may also suggest that other
important social factors are still missing in such analyses
to explain differences in residual incidence.
As CD is known to be modulated by specific genetic
markers [31], the possible importance of genetic suscepti-
bility of homogeneous patches of sub-populations is
another important element when interpreting the data
from the province of Quebec. The unique population
genetic structure of this province is well documented and
population characteristics consequent to founder effect,
genetic drift and endogamy are known to have influenced
the current prevalence and regional distribution of sev-
eral genetic diseases [32-36]. As proposed by Laberge et
al. [32], these characteristics have consequences not only
on the distribution of monogenic diseases but also on
other health conditions modulated by genetic susceptibil-
ity. Further attention should be given to investigate the
possible link between the genetic profile of sub-popula-
tions of this province and regional clusters of high or low
CD incidence residuals as illustrated in figure 2 and 4 of
this study.
We also described a significant west to east increasing
trend in the incidence residuals for the province of Que-
bec, which corresponds to the trend observed by Bern-
stein  et al. [37] for the rest of Canada. Given the
heterogeneous pattern in the spatial distribution of inci-
dence residuals, the location of health areas with most
extreme values and the relative small territory under
study (one province), the eastern trend in the incidence
residuals has to be interpreted with caution. It might only
reflect that fewer health areas with large negative residu-
Figure 1 Crohn's Disease Standardized Cumulative Incidence (1995 - 2000). Incidence rates were transformed using empirical Bayesian smooth-
ing function (EBS) and represent age and sex directly standardized cumulative measures. The classification is based on a standard deviation bi-direc-
tional method.
Montréal Area
Province of Québec, Canada
Ontario
St-Lawrence River
EBS CD Incidence (per 104 pop)
Very low (less than 10.1)
 Low (10.2 - 12.7)
Average (12.8 - 15.3)
High (15.4 - 17.9)
Very high (more than 18.0)Michel et al. International Journal of Health Geographics 2010, 9:22
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als were along the western border of the province and the
areas with the largest positive residual were located at the
very eastern side of the province. This finding, however,
raises the interest of investigating carefully the CD inci-
dence rates in regions adjacent to these "extreme" values,
along the eastern border of the Ontario province, along
the northern areas of the states of Vermont and New
York, and across the Atlantic provinces of Canada. Under
the assumption that environmental physical factors have
common influence over both side of the administrative
boundaries, these cross-border assessment of CD occur-
rence might provide initial clues to discriminate possible
effect of health systems (surveillance and diagnostic
efforts) from environmental or population effects for
these regions. Of course, this west-to-east apparent trend,
both at the national and provincial level is intriguing and
may also reveals true but unmeasured effects linked to
the genetic profile of regional populations, cultural fac-
tors (diet, traditions) or broader factors influencing envi-
ronmental conditions such as the climate, soil
composition or agricultural practices.
It is also worth noting that our data revealed that the
CD incidence residuals were not influenced by the rural/
urban profile of the health regions in the southern part of
the province of Quebec. Several studies have reported a
regional association between CD occurrence and urba-
nicity, some describing a positive association with urban
location [37-40], some describing a positive association
with rural location [41] and others not finding any signifi-
cant associations [30,42,43]. From this, we may suggest
that this proxy variable may capture a mixture of unmea-
sured but geographically heterogeneous or dynamic envi-
ronmental exposures including effects from microbial
quality of water, contact with animals, or occupation
which should be further investigated and incorporated in
geographical models.
Several other communications have proposed sets of
environmental variables comparable to the one used in
this analysis and other groups have studied the associa-
tion between CD and water supply [44], early-life expo-
sures with antibiotic use [45], food and intestinal
microbes [46] and have shown some significant associa-
Figure 2 Crohn's Disease Residual Incidence (1995 - 2000). Values represents empirical Bayesian smoothed (EBS) incidence residuals from a re-
gression model adjusting for the regional effect of immigration, population of Jewish ethnicity, population of Aboriginal ancestry, incidence of enteric 
diseases and socio-economic status. Positive values reflect a larger observed incidence than predicted by the model (under-estimation) and negative 
values reflect a smaller observed incidence than the one predicted by the model (over-estimation). Patches of areas with lower values (i.e. regions A 
and E), higher values (i.e. regions B and F) and with discordant values (i.e. regions D and C) are illustrated.
Montréal Area
Province of Québec, Canada
Ontario
St-Lawrence River
EBS CD incidence residuals
(per 104 pop)
-9.84 - -5.23
-5.23 - -1.78
-1.78 - 0.86
0.86 - 4.62
4.62 - 11.74
Region D
Region F
Region C
Region B
Region A
Region EMichel et al. International Journal of Health Geographics 2010, 9:22
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tions, but very few details were given on any aspects of
the model fit and performance. If we put aside consider-
ations relative to model specifications (i.e. whether we
use a negative-binomial model or an explicit spatial
model) and the inherent effect of ecological bias affecting
inevitably a design such as the one used in this study, the
most common reasons affecting a model with relative low
performance often include: 1. the lack of important vari-
ables; 2. the inadequate or unspecific construction of one
or many variables; 3. inadequate choice of the geographi-
cal unit in relation to the distribution of the predictors;
and 4. data errors and misclassification. In a geographical
study like ours, misclassification bias may arise mainly
from two components, namely from the application of
the outcome definition (classifying a patient as CD) and
from geo-positioning cases within a given health area.
We have no reason to believe that the misclassification,
for both of these components, would be differential. In
this case, the consequence of this bias often leads to con-
servative estimates from the model [47]. The RAMQ
database has also been used to study other health condi-
tions and found to provide a valid description of out-
comes [48].
Due to the exploratory nature of the current analysis, it
was not possible to fully assess the relative contribution
of these factors on the performance of our model. How-
ever, given the marked effort that was given in this study
to minimize possible biases that might be attributable to
the construction of variables, misclassification, model
specification and geographical unit, we postulate that
important regional-level factors are still missing as key
predictors to the geographical variation of CD incidence
rates. The above considerations, namely the spatial het-
erogeneity and the likelihood of missing important envi-
ronmental factors represent further evidence in support
of a complex interaction of population-level factors and
triggers from the physical and social environment in
explaining CD epidemiology.
Conclusions
Our study suggest that the geographical distribution of
incident cases of Crohn's disease in the province of Que-
bec presented a marked spatial heterogeneity above the
one that could be explained by the distribution of
regional factors used in this analysis. This finding further
supports the presence of unmeasured regional compo-
Figure 3 Local Indicators Of Spatial Autocorrelation (LISA) Of CD Residual Incidence. Significant negative spatial association (Low/Low) is 
shown in grey while significant positive association is colored green (High/High). Areas that had non-significant LISA values are represented with no 
color shading.
Montréal Area
Province of Québec, Canada
Ontario
St-Lawrence River
Local autocorrelation
High / Low or Low / High
No significance
High / High
Low / LowMichel et al. International Journal of Health Geographics 2010, 9:22
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nents to the etiology of CD, potentially acting as a trigger
or as a necessary co-factor to the development of the dis-
ease. CD is a complex disease and other social, genetic,
and environmental factors potentially characterizing geo-
graphical areas with incidence rates well above or below
average should be further investigated.
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Figure 4 Health Areas With Most Extreme Incidence Residuals Of CD (1995 - 2000). Health areas in Quebec with largest residuals according to 
a regression model accounting for known regional risk factors. Residual values were smoothed using an empirical Bayes (EBS) method. EBS-residuals 
larger and smaller than two standard deviations from the mean (zero) were tagged as "largest residuals". Areas in green reflect locations of largest 
residuals corresponding to an overestimation of the statistical model and areas in grey reveal locations of largest residuals corresponding to an un-
derestimation of the model.
 ID Health area  CD freq Pop DSR DSR residuals
16041 Chateauguay-Mercier 27 68423 4.05 -9.86
7021 Pontiac 7 20549 3.37 -8.87
11032 Grande-Vallee 2 3325 5.67 -8.68
8021 Ville-Marie 8 14412 5.81 -7.39
6094 Montreal-Centre-Ville 17 8544 19.15 7.63
16101 Cowansville-Farnham-Bedford 120 49902 25.21 9.02
2061 Lac-Saint-Jean-Est 127 53093 24.40 9.43
4022 Des Chenaux 28 12460 25.38 10.75
11021 Pabok 53 20101 26.53 11.82
Province of Québec,
Canada
Ontario
Over-estimates
Under-estimates
Estimation errorMichel et al. International Journal of Health Geographics 2010, 9:22
http://www.ij-healthgeographics.com/content/9/1/22
Page 9 of 9
goranska County, Croatia, 2000-2004: A prospective population-based 
study.  Scand J Gastroenterol 2006, 41:437-444.
10. Green C, Elliott L, Beaudoin C, Bernstein CN: A population-based ecologic 
study of inflammatory bowel disease: searching for etiologic clues.  Am 
J Epidemiol 2006, 164:615-623.
11. Lowe AM, Roy PO, Poulin M, Michel P, Bitton A, St Onge L, Brassard P: 
Epidemiology of Crohn's disease in Quebec, Canada.  Inflamm Bowel Dis 
2009, 15:429-435.
12. Régie de l'assurance maladie du Québec. Statistiques annuelles.  2000.
13. Ayanian JZ: Using administrative data to assess health care outcomes.  
Eur Heart J 1999, 20:1689-1691.
14. Monfared AA, Lelorier J: Accuracy and validity of using medical claims 
data to identify episodes of hospitalizations in patients with COPD.  
Pharmacoepidemiol Drug Saf 2006, 15:19-29.
15. Anselin L: Local indicators of spatial association - LISA.  Geographical 
Analysis 1995, 27:93-115.
16. Elliott P, Savitz DA: Design issues in small-area studies of environment 
and health.  Environ Health Perspect 2008, 116:1098-1104.
17. Kanauchi O, Mitsuyama K, Andoh A: The therapeutic impact of 
manipulating microbiota in inflammatory bowel disease.  Curr Pharm 
Des 2009, 15:2074-2086.
18. Hartman C, Eliakim R, Shamir R: Nutritional status and nutritional 
therapy in inflammatory bowel diseases.  World J Gastroenterol 2009, 
15:2570-2578.
19. Lucendo AJ, De Rezende LC: Importance of nutrition in inflammatory 
bowel disease.  World J Gastroenterol 2009, 15:2081-2088.
20. Goh K, Xiao SD: Inflammatory bowel disease: a survey of the 
epidemiology in Asia.  J Dig Dis 2009, 10:1-6.
21. Li X, Sundquist J, Sundquist K: Educational level and occupation as risk 
factors for inflammatory bowel diseases: A nationwide study based on 
hospitalizations in Sweden.  Inflamm Bowel Dis 2009, 15:608-615.
22. Jiang L, Xia B, Li J, Ye M, Yan W, Deng C, Ding Y, Luo H, Hou W, Zhao Q, Liu 
N, Ren H, Hou X, Xu H: Retrospective survey of 452 patients with 
inflammatory bowel disease in Wuhan city, central China.  Inflamm 
Bowel Dis 2006, 12:212-217.
23. Cucino C, Sonnenberg A: Occupational mortality from inflammatory 
bowel disease in the United States 1991-1996.  Am J Gastroenterol 2001, 
96:1101-1105.
24. Van Den BJ, Cahill J, Emmanuel AV, Vaizey CJ, Talbot IC, Knight SC, Kamm 
MA: Gut mucosal response to food antigens in Crohn's disease.  Aliment 
Pharmacol Ther 2002, 16:1903-1915.
25. Mekkel G, Barta Z, Ress Z, Gyimesi E, Sipka S, Zeher M: [Increased IgE-type 
antibody response to food allergens in irritable bowel syndrome and 
inflammatory bowel diseases].  Orv Hetil 2005, 146:797-802.
26. Joseph AJ, George B, Pulimood AB, Seshadri MS, Chacko A: 25 (OH) 
vitamin D level in Crohn's disease: association with sun exposure & 
disease activity.  Indian J Med Res 2009, 130:133-137.
27. Peyrin-Biroulet L, Oussalah A, Bigard MA: Crohn's disease: the hot 
hypothesis.  Med Hypotheses 2009, 73:94-96.
28. Pineton dC, Colombel JF, Poulain D, Darfeuille-Michaud A: Pathogenic 
agents in inflammatory bowel diseases.  Curr Opin Gastroenterol 2008, 
24:440-447.
29. Behr MA, Kapur V: The evidence for Mycobacterium paratuberculosis in 
Crohn's disease.  Curr Opin Gastroenterol 2008, 24:17-21.
30. Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P: Small-area variations 
and sociodemographic correlates for the incidence of Crohn's disease 
and ulcerative colitis.  Am J Epidemiol 2001, 154:328-335.
31. Noomen CG, Hommes DW, Fidder HH: Update on genetics in 
inflammatory disease.  Best Pract Res Clin Gastroenterol 2009, 23:233-243.
32. Laberge AM: [Prevalence and distribution of genetic diseases in 
Quebec: impact of the past on the present].  Med Sci (Paris) 2007, 
23:997-1001.
33. Laberge AM, Michaud J, Richter A, Lemyre E, Lambert M, Brais B, Mitchell 
GA: Population history and its impact on medical genetics in Quebec.  
Clin Genet 2005, 68:287-301.
34. Moreau C, Vezina H, Yotova V, Hamon R, de Knijff P, Sinnett D, Labuda D: 
Genetic heterogeneity in regional populations of Quebec--parental 
lineages in the Gaspe Peninsula.  Am J Phys Anthropol 2009, 139:512-522.
35. Bhat M, Nguyen GC, Pare P, Lahaie R, Deslandres C, Bernard EJ, Aumais G, 
Jobin G, Wild G, Cohen A, Langelier D, Brant S, Dassopoulos T, McGovern 
D, Torres E, Duerr R, Regueiro M, Silverberg MS, Steinhart H, Griffiths AM, 
Elkadri A, Cho J, Proctor D, Goyette P, Rioux J, Bitton A: Phenotypic and 
genotypic characteristics of inflammatory bowel disease in French 
Canadians: comparison with a large North American repository.  Am J 
Gastroenterol 2009, 104:2233-2240.
36. Scriver CR: Human genetics: lessons from Quebec populations.  Annu 
Rev Genomics Hum Genet 2001, 2(69-101):69-101.
37. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson 
M, Fedorak R, Israel D, Blanchard JF: The epidemiology of inflammatory 
bowel disease in Canada: a population-based study.  Am J Gastroenterol 
2006, 101:1559-1568.
38. Green C, Elliott L, Beaudoin C, Bernstein CN: A population-based ecologic 
study of inflammatory bowel disease: searching for etiologic clues.  Am 
J Epidemiol 2006, 164:615-623.
39. Aamodt G, Jahnsen J, Bengtson MB, Moum B, Vatn MH: Geographic 
distribution and ecological studies of inflammatory bowel disease in 
southeastern Norway in 1990-1993.  Inflamm Bowel Dis 2008, 
14:984-991.
40. Sincic BM, Vucelic B, Persic M, Brncic N, Erzen DJ, Radakovic B, Micovic V, 
Stimac D: Incidence of inflammatory bowel disease in Primorsko-
goranska County, Croatia, 2000-2004: A prospective population-based 
study.  Scand J Gastroenterol 2006, 41:437-444.
41. Declercq C, Gower-Rousseau C, Vernier-Massouille G, Salleron J, Balde M, 
Poirier G, Lerebours E, Dupas JL, Merle V, Marti R, Duhamel A, Cortot A, 
Salomez JL: Mapping of inflammatory bowel disease in northern 
France: Spatial variations and relation to affluence.  Inflamm Bowel Dis 
2010, 16:804-806.
42. Button LA, Roberts SE, Goldacre MJ, Akbari A, Rodgers SE, Williams JG: 
Hospitalized prevalence and 5-year mortality for IBD: record linkage 
study.  World J Gastroenterol 2010, 16:431-438.
43. Skrzydlo-Radomanska B, Radwan P, Radwan-Kwiatek K: Retrospective 
analysis of hospital admissions of patients with ulcerative colitis and 
Crohn's disease from semi-rural and rural regions in the Department of 
Gastroenterology in Lublin between 2000- 2006.  Ann Agric Environ Med 
2008, 15:193-197.
44. Aamodt G, Bukholm G, Jahnsen J, Moum B, Vatn MH: The association 
between water supply and inflammatory bowel disease based on a 
1990-1993 cohort study in southeastern Norway.  Am J Epidemiol 2008, 
168:1065-1072.
45. Hildebrand H, Malmborg P, Askling J, Ekbom A, Montgomery SM: Early-
life exposures associated with antibiotic use and risk of subsequent 
Crohn's disease.  Scand J Gastroenterol 2008, 43:961-966.
46. Asakura H, Suzuki K, Kitahora T, Morizane T: Is there a link between food 
and intestinal microbes and the occurrence of Crohn's disease and 
ulcerative colitis?  J Gastroenterol Hepatol 2008, 23:1794-1801.
47. Rothman KJ, Greenland S: Precision and Validity in Epidemiologic 
Studies.  In Modern Epidemiology 2nd edition. Edited by: Rothman KJ, 
Greenland S. Lippincot; Raven; 1998. 
48. McKnight J, Scott A, Menzies D, Bourbeau J, Blais L, Lemiere C: A cohort 
study showed that health insurance databases were accurate to 
distinguish chronic obstructive pulmonary disease from asthma and 
classify disease severity.  J Clin Epidemiol 2005, 58:206-208.
doi: 10.1186/1476-072X-9-22
Cite this article as: Michel et al., Geographical variation of Crohn's disease 
residual incidence in the Province of Quebec, Canada International Journal of 
Health Geographics 2010, 9:22